SOUTHERN MONO HEALTH CARE DISTRICT
1. Target Overview & Investment Thesis
SOUTHERN MONO HEALTH CARE DISTRICT is a 17-bed suburban community hospital in MONO, CA with $99.1M in net patient revenue and a 4.1% operating margin. The hospital serves a payer mix of 29.8% Medicare, 12.8% Medicaid, and 57.4% commercial.
Thesis: Turnaround. Our ML models identify $7.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.1% to 11.4% (+736bps).
| Net Revenue HCRIS | $99.1M |
| Current EBITDA COMPUTED | $4.0M |
| Operating Margin COMPUTED | 4.1% |
| Occupancy HCRIS | 19.3% |
| Revenue / Bed COMPUTED | $5.8M |
| Net-to-Gross HCRIS | 61.7% |
| Distress Probability ML | 53.9% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 4.1% places it above the state median. Among 54 size-comparable peers (8-34 beds), the median margin is -10.9%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (8-34), prioritizing same-state peers. 54 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SOUTHERN MONO HEALTH CARE DIST (Target) | CA | 17 | $99.1M | 4.1% |
| TAHOE FOREST HOSPITAL | CA | 25 | $264.3M | 13.0% |
| PORTERVILLE DEVELOPMENTAL CENT | CA | 17 | $193.6M | -6.0% |
| ADVENTIST HEALTH CLEARLAKE | CA | 25 | $159.9M | -6.3% |
| RIDGECREST REGIONAL HOSPITAL | CA | 25 | $149.6M | -14.7% |
| HAZEL HAWKINS MEM. HOSPITAL | CA | 25 | $141.1M | -16.7% |
| GOLETA VALLEY COTTAGE HOSPITAL | CA | 24 | $111.9M | 14.8% |
| FAIRCHILD MEDICAL CENTER | CA | 25 | $109.4M | -0.3% |
| NORTHERN INYO HOSPITAL | CA | 25 | $105.4M | -33.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $63K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $4.0M |
| + RCM Uplift | +$7.3M |
| Pro Forma EBITDA | $11.3M |
| Current Margin | 4.1% |
| Pro Forma Margin | 11.4% |
| WC Released (1x) | $3.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $6.2M | $99.5M | 16.08x | 74.3% |
| Base (11x exit) | 10.0x | 11.0x | $6.2M | $111.5M | 18.01x | 78.3% |
| Bull Case | 9.0x | 11.0x | $5.6M | $137.6M | 24.69x | 89.9% |
| Bull (12x exit) | 9.0x | 12.0x | $5.6M | $151.7M | 27.23x | 93.7% |
| Bear Case | 11.0x | 10.0x | $6.8M | $61.0M | 8.96x | 55.0% |
| Bear (11x exit) | 11.0x | 11.0x | $6.8M | $69.3M | 10.18x | 59.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 19.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 53.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 54 hospitals with 8-34 beds
- Same-state prioritization (n=58)
- Comp margins: P25=-22.5% / P50=-10.9% / P75=0.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.